INNV Shareholder/Stockholder Letter Transcript:
ANNUAL REPORT 2024
DECADES OF DEDICATION,
A Lifetime of Care.
PACE Program of All-inclusive Care for the Elderly
ANNUAL
REPORT
2024
Annual Meeting
The Annual Meeting will be held on Thursday, December 5, 2024 at
9:00 AM ET, via live audio webcast at
ZZZ YLUWXDOVKDUHKROGHUPHHWLQJ FRP ,119
Stockholders will be able to submit questions and vote electronically during the meeting by logging in using
the 16-digit control number included on the Notice of Internet Availability of Proxy Materials, proxy card or
voting instruction form.
Board of Directors
James Carlson
Chair of the Board
Patty Fonteneau
Director
Teresa Sparks
Director
John Ellis Bush
Director
Ted Kennedy, JU
Director
Marilyn Tavenner
Director
Andrew Cavanna
Director
Thomas Scully
Director
Richard Zoretic
Director
Richard Feifer
Chief Medical Officer
Nicole D Amato
Chief Legal Officer and
Corporate Secretary
Executive Officers
Patrick Blair
President and Chief
Executive Officer
Benjamin Adams
Chief Financial Officer
Common Stock Listed (INNV)
NASDAQ Stock Exchange
Christine Bent
Chief Operating Officer
Independent Accountants
Deloitte & Touche LLP
1601 Wewatta Street, Suite 400
Denver, CO 80203
(303) 292-5400
www.deloitte.com
Transfer Agent
Equiniti Trust Company LLC
Attn: Shareholder Services
55 Challenger Road , Floor 2
Ridge eld Park, NJ 07660
Phone: (800) 937-5449 or (718) 921-8124
Email: helpAST@equiniti.com
Website: www.equiniti.com
2024
We deliver comprehensive, personalized care which includes all
Medicare and Medicaid services
As of 06/30/2024
We believe we can deliver better health outcomes, improved quality, and
increased satisfaction while lowering costs
in review
We leverage a comprehensive care model, integrating multiple streams of
resources, to enable individuals to live in their homes and communities
WE SERVE APPROXIMATELY
7,020
AND HAVE
FOR MORE
THAN
PARTICIPANTS
35
YEARS
WE OPERATE
20
NEIGHBORHOOD
CARE CENTERS
Addressable Lives (1)
$260bn
Addressable Market
Opportunity (2)
6
STATES
$764mm
2.3mm
IN
FY2024 Total Revenue
$132mm
Center-Level Contribution
Margin(3)
$16.5mm Adjusted EBITDA
2.2% Adjusted EBITDA Margin
(3)
(3)
(1) Based on company estimates on data from the U.S. Census Bureau from 2018, which are subject to change.
See Cautionary Note About Forward-Looking Statements in the attached Form 10-K.
(2) Based on internal estimates based on our estimated market of approximately 2.3 million PACE eligible in the
United States in 2023.
(3) Center-level Contribution Margin, Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures.
Effective for the year ended June 30, 2024, the Company has revised its calculation of Adjusted EBITDA and has
recast the presentation for the year ended June 30, 2023 to conform to the current presentation. For more
details and for a de nition and reconciliation of these non-GAAP measures to the most closely comparable
GAAP measures for the periods indicated, see Note Regarding Use of Non-GAAP Financial Measures and
Reconciliation of GAAP and Non-GAAP Measures. in the attached Form 10-K.
10/25/2024 Letter Continued (Full PDF)